Russell Investments Group
TNXP icon

Russell Investments Group’s Tonix Pharmaceuticals TNXP Stock Holding History

Russell Investments Group’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12K Sell
870
-394
-31% -$6.07K ﹤0.01% 3757
2025
Q4 		$19.7K Buy
1,264
+66
+6% +$1.22K ﹤0.01% 3632
2025
Q3 		$28.9K Buy
+1,198
New +$44.5K ﹤0.01% 3480
2023
Q1 		– Hold
0
– – – 3385
2022
Q4 		– Hold
0
– – – 2964
2022
Q3 		– Hold
0
– – – 2977
2022
Q2 		– Hold
0
– – – 2964

Other funds holding TNXP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Russell Investments Group's TNXP Position: Q1 2026 in Review

Russell Investments Group reduced its Tonix Pharmaceuticals (TNXP) stake by 31% in Q1 2026, selling an estimated $6.07K and leaving 870 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #3757.

Russell Investments Group first reported a position in TNXP in Q3 2025 and has held it in 3 quarters since. The position peaked at $28.9K in Q3 2025. 81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.

  • Russell Investments Group held 870 shares of Tonix Pharmaceuticals worth $12K as of Q1 2026.
  • Russell Investments Group sold 394 Tonix Pharmaceuticals shares in Q1 2026, an estimated $6.07K.
  • Tonix Pharmaceuticals made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3757 holding.
  • Russell Investments Group first reported a position in Tonix Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Russell Investments Group's Tonix Pharmaceuticals position peaked at $28.9K in Q3 2025.
  • 81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.